HBSP (USA)
-
Synthetic Biology Investment Opportunity
Barrett, Peter; Lakhani, Karim R.; Kelley, Julia; Herman, KerryCase HBS-620015-EInformation TechnologiesStarting at €8.20
-
Celgene: Business Development and Distributed Research
Barrett, Peter; Reda, KareemCase HBS-620014-EKnowledge and CommunicationThis case looks at the deal-making process between Celgene, a large publicly traded pharmaceutical company, and Agios, an early-stage biotech company. The framework of a potential deal is explored and the potential road-blocks to Agios' profitability are discussed. The relationship between a fledgling biotech company and an established pharmaceutical company as well as the expectations from both sides regarding their deal are examined.Starting at €8.20
-
Note on Funding Deep Tech Startups
Lakhani, Karim R.; Barrett, Peter; Afeyan, Noubar B.Case HBS-620029-EEntrepreneurshipThis note provides essential information on funding sources and valuation topics facing deep technology startups-ventures that are capital-intensive, with high technical and market uncertainty, and require long gestation periods. Both dilutive and non-dilutive sources of investment are described, along with empirical examples and figures.Starting at €8.20
-
Kymera Therapeutics: Building a Biotech Execution Plan
Barrett, Peter; Lakhani, Karim R.Case HBS-620017-EService and Operations ManagementStarting at €8.20